APA (7th ed.) Citation

Li, L., Ren, T., Liu, K., Li, M., Geng, Y., Yang, Y., . . . Liu, Y. (2021). Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Frontiers in Oncology, 11, . https://doi.org/10.3389/fonc.2021.692647

Chicago Style (17th ed.) Citation

Li, Lin, et al. "Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit." Frontiers in Oncology 11 (2021). https://doi.org/10.3389/fonc.2021.692647.

MLA (9th ed.) Citation

Li, Lin, et al. "Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit." Frontiers in Oncology, vol. 11, 2021, https://doi.org/10.3389/fonc.2021.692647.